Spitalul Clinic De Boli Infectioase Constanta — Clinical Trial Site

10 Registered trials

5 Currently recruiting

Organisation

Spitalul Clinic De Boli Infectioase Constanta

Location

Constanta, Romania

Identifier

ORG-100047728

Address

Bulevardul Ferdinand 100, 900709, Romania

Departments

Boli Infectioase Adulti II
Boli Infectioase II
Compartiment de Cercetare
Infectious Disease Department
Infectious Diseases
Infectious Diseases and Epidemiology
Infectious Diseases II
Secţia Boli Infecţioase Adulţi II

Clinical trials at this site (10)

Search interface

Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen (TILIA). Recruiting

2023-507031-38-00 Severe viral lung infections 5 2023-01-09
Phase 2b/3 Study to Evaluate Switching to Brelovitug for the Treatment of CHD in Participants Receiving Bulevirtide Recruiting

2025-522015-42-00 Chronic Hepatitis D Infection 10 2026-02-26
A Global, Randomized, Open-label, Multicenter Phase 3 Trial Evaluating BJT-778 vs Bulevirtide for the Treatment of Chronic Hepatitis Delta I… Recruiting

2024-517167-23-00 Chronic Hepatitis D Infection 5 2025-08-28
Clinical trial of molnupiravir (MK-4482) in adults who have COVID-19 and are not hospitalized, who are at high risk for serious illness from… Recruiting

2023-507227-36-00 SARS-CoV-2 (COVID-19) infection 5 2025-02-21
RECOVERY Recruiting

2023-507441-29-00 Pneumonia 5 2024-02-29
A Phase 3 Trial Comparing Whether BEM/RZR is Similar to SOF/VEL in Patients with Hepatitis C Virus Infection Ended

2025-521096-31-00 Chronic Hepatitis C Virus (HCV) Infection 5 2025-10-02
Study of Oral Weekly GS-1720 and GS-4182 Compared With Biktarvy in People With HIV-1 Who Have Not Been Treated Ended

2024-512505-66-00 HIV-1 Infection 10 2025-03-03
STUDY TO EVALUATE THE SAFETY AND EFFICACY OF BEMNIFOSBUVIR AND RUZASVIR IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION Ended

2023-504566-28-00 Chronic Hepatitis C Virus (HCV) Infection 4 2023-05-19
A study to evaluate the efficacy and safety of Bemnifosbuvir in High-Risk Outpatients with COVID-19 Ended

2023-504540-33-00 COVID-19 5 2023-03-06
Phase 3 Study of Bepirovirsen in Nucleos(t)ide Analogue-treated Participants with Chronic Hepatitis B (B-Well 2) Ended

2023-504238-23-00 Hepatitis B, Chronic 5 2023-01-17